Abstract

Low molecular weight poly(e-caprolactone) (PCL) and α-cyclodextrin (α-CD) favor forming crystallized peseudopolyrotaxanes in most of solvents, which impedes their biomedical application. This work provides an example of site-specific polymer functionalization of PCL to control the hierachical assembly with CDs to form novel supramolecular polymer micelles (SMPMs). The unique design of functional PCL includes the introduction of anticancer drug doxorubicin (Dox) with a larger molecular volume as the steric group into the backbone of PCL to realize the partial inclusion complex of PCL with α-CD. This inclusion complex can then self assemble into SMPMs with an average size of around 20 nm in aqueous solution due to the hydrophobic–hydrophilic interaction. The structure and morphology of the SMPMs were investigated and revealed by comprehensive characterizations including 1HNMR, XRD and TEM, TGAetc., their controlled drug release and cell internalization behavior were also explored. The above proof of concept paves the way for a new strategy for self-assembly and overcomes the dispersion of pseudopolyrotaxanes, also, the micelles formed show great promise in biomedical applications, especially in controlled drug release.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.